Polypills with or without aspirin for primary prevention of cardiovascular disease

Polypills with or without aspirin for primary prevention of cardiovascular disease

Библиографические подробности
Главные авторы:	Mant, J, McManus, R
Формат:	Journal article
Язык:	English
Опубликовано:	Elsevier 2021

Схожие документы

Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study
по: Virdee, S, и др.
Опубликовано: (2013)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease
по: Jowett, S, и др.
Опубликовано: (2017)

Polypill for cardiovascular disease prevention.
по: Dalton, A
Опубликовано: (2013)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease.
по: Sue Jowett, и др.
Опубликовано: (2017-01-01)

The Concept of the Polypill in the Prevention of Cardiovascular Disease
по: Brandon Wiley, и др.
Опубликовано: (2014-04-01)

Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
по: J. Masjuan, и др.
Опубликовано: (2021-01-01)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
по: Omneya A. Kandil, и др.
Опубликовано: (2022-04-01)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
по: Apichard Sukonthasarn, и др.
Опубликовано: (2021-03-01)

Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study.
по: Sheppard, J, и др.
Опубликовано: (2014)

Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review
по: Lopez-Lopez JP, и др.
Опубликовано: (2023-09-01)

A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization
по: Gunaratne Padma S, и др.
Опубликовано: (2011-01-01)

Medicinal herbs: Potential polypills in cardiovascular diseases
по: Samaneh Noroozi, и др.
Опубликовано: (2021-04-01)

Exercise Rehabilitation in Heart Disease: the real “polypill” for primary and secondary prevention
по: Massimo F. Piepoli
Опубликовано: (2005-06-01)

The polypill: the solution for prevention of coronary heart disease?
по: Hendarto Natadidjaja
Опубликовано: (2016-02-01)

Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study.
по: Sheppard, J, и др.
Опубликовано: (2012)

THE ROLE OF POLYTABLETS (POLYPILL) IN THE TREATMENT OF CHRONIC CARDIOVASCULAR DISEASES
по: Николай Владимирович Абрамов, и др.
Опубликовано: (2024-02-01)

Role of aspirin in primary prevention of cardiovascular disease
по: Patrono, C, и др.
Опубликовано: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
по: VanWormer JJ, и др.
Опубликовано: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
по: Ying Xing, и др.
Опубликовано: (2019-07-01)

Polypill versus medication monotherapy in the prevention of cardiovascular diseases in Iran: An economic evaluation study
по: Ramin Ravangard, и др.
Опубликовано: (2024-07-01)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
по: Lilian Grigorian-Shamagian, и др.
Опубликовано: (2021-08-01)

Maybe it's time for something a little different? The extent to which current pharmacotherapy practice conforms to national guidelines for primary for cardiovascular disease prevention
по: Sheppard, J, и др.
Опубликовано: (2013)

The use of polypills in cardiovascular disease management: Benefits vs challenges
по: Yamaan Adil, и др.
Опубликовано: (2024-09-01)

Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review.
по: Reza Jahangiri, и др.
Опубликовано: (2022-01-01)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
по: Hennekens, C, и др.
Опубликовано: (1989)

A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
по: Gautam Satheesh, и др.
Опубликовано: (2024-07-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
по: Yinong Chen, и др.
Опубликовано: (2021-09-01)

Redefining the polypill: pros and cons in cardiovascular precision medicine
по: Siddharth Birla, и др.
Опубликовано: (2023-09-01)

Which people should take aspirin for primary prevention of cardiovascular disease?
по: Lozano R, и др.
Опубликовано: (2015-07-01)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
по: Sergio Coccheri
Опубликовано: (2017-04-01)

Aspirin for prevention of cancer and cardiovascular disease.
по: Rose, P, и др.
Опубликовано: (2011)

Correction: A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
по: Gautam Satheesh, и др.
Опубликовано: (2024-08-01)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
по: Eleni Giannopoulou, и др.
Опубликовано: (2024-12-01)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
по: Athena L. Huang, и др.
Опубликовано: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
по: Athena L. Huang, MD, и др.
Опубликовано: (2023-09-01)

Preventing the progression of climate change: one drug or polypill?
по: Hugh Montgomery
Опубликовано: (2017-03-01)

Maybe it's time for something a little different? The extent to which current pharmacotherapy practice conforms to national guidelines for stroke and cardiovascular disease prevention
по: Sheppard, J, и др.
Опубликовано: (2013)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
по: Price, H, и др.
Опубликовано: (2009)

Polypill holds promise for people with chronic disease
по: Jacqui Wise
Опубликовано: (2005-12-01)

Aspirin in the primary prevention of vascular disease Reply
по: Baigent, C, и др.
Опубликовано: (2009)